Trueblood Wealth Management’s First Trust Mid Cap Core AlphaDEX Fund FNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$240K Buy
1,777
+5
+0.3% +$716 0.08% 241
2026
Q2
$259K Buy
1,772
+3
+0.2% +$416 0.09% 232
2026
Q1
$227K Buy
1,769
+4
+0.2% +$530 0.09% 239
2025
Q4
$222K Buy
1,765
+4
+0.2% +$501 0.09% 237
2025
Q3
$221K Buy
1,761
+3
+0.2% +$363 0.09% 242
2025
Q2
$202K Buy
+1,758
New +$191K 0.08% 242

Other funds holding FNX

Trueblood Wealth Management's FNX Position: Q3 2026 in Review

Trueblood Wealth Management increased its First Trust Mid Cap Core AlphaDEX Fund (FNX) stake by 0.28% in Q3 2026, buying an estimated $716 and bringing the position to 1,777 shares worth $240K. The position accounts for 0.08% of the portfolio, ranked #241.

Trueblood Wealth Management first reported a position in FNX in Q2 2025 and has held it in 6 quarters since. The position peaked at $259K in Q2 2026. 207 funds tracked by Wall St. Rank hold FNX as of Q3 2026.

  • Trueblood Wealth Management held 1,777 shares of First Trust Mid Cap Core AlphaDEX Fund worth $240K as of Q3 2026.
  • Trueblood Wealth Management bought 5 First Trust Mid Cap Core AlphaDEX Fund shares in Q3 2026, an estimated $716.
  • First Trust Mid Cap Core AlphaDEX Fund made up 0.08% of Trueblood Wealth Management's portfolio in Q3 2026, its #241 holding.
  • Trueblood Wealth Management first reported a position in First Trust Mid Cap Core AlphaDEX Fund in Q2 2025 and has held it in 6 quarters since.
  • Trueblood Wealth Management's First Trust Mid Cap Core AlphaDEX Fund position peaked at $259K in Q2 2026.
  • 207 funds tracked by Wall St. Rank held First Trust Mid Cap Core AlphaDEX Fund as of Q3 2026.

Based on Trueblood Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.